AzTrials
AzTrials

ArthroplastyNCT02415465

Continuous Adductor Canal Block (CACB) vs. Combined Spinal Epidural (CSE) in Total Knee Arthroplasty

A study testing Continuous Adductor Canal Block, General and Epidural in people with Arthroplasty, run by Rush University Medical Center at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Purpose: Compare continuous adductor canal block (CACB) to Combined Spinal Epidural (CSE) for total knee arthroplasty in terms of mobility, post-operative pain, and analgesic use. Hypothesis: CACB will provide better mobility than CSE post operatively. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Arthroplasty
What is being tested?
Continuous Adductor Canal Block, General and Epidural
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
157 participants
Where
1 siteUnited States
Study dates
Jan 2015to Mar 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Any patient scheduled for a primary unilateral TKA.

Who cannot join

  • Partial knee replacement,
  • chronic opioid use,
  • history of alcohol or drug abuse,
  • preexisting neuropathy in operative limb,
  • allergy to local anesthetics,
  • ASA Class >3,
Show all 9Show fewer
  • patients who decline to participate,
  • BMI >40,
  • sleep apnea.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Rush University Medical Center

    Chicago, Illinois, 60612

Other trials in United States

About this study

Purpose: Compare continuous adductor canal block (CACB) to Combined Spinal Epidural (CSE) for total knee arthroplasty in terms of mobility, post-operative pain, and analgesic use.

Hypothesis: CACB will provide better mobility than CSE post operatively.

Read the detailed description

Purpose: Compare continuous adductor canal block (CACB) to Combined Spinal Epidural (CSE) for total knee arthroplasty in terms of mobility, post-operative pain, and analgesic use.

Hypothesis: CACB will provide better mobility than CSE post operatively.

Background/Scientific Review:

Total knee arthroplasty (TKA) is associated with varying degrees of pain post operatively ranging from mild to severe despite the use of comprehensive multimodal analgesic regimens1. Optimizing pain relief is vital for functional recovery after total knee arthroplasty2. Peripheral nerve blocks have been commonly used to improve pain relief and reduce opioid requirements. The addition of nerve blocks involving the femoral nerve have been shown to provide superior pain control3 and shortened hospital stay compared to epidural or intravenous patient controlled analgesia alone1. However, femoral nerve blocks can result in quadriceps weakness leading to functional impairment and an increased risk of falling post operatively4. Unlike Femoral Nerve Blocks (FNB), adductor canal blocks (ACB) are predominantly sensory blocks which preserve quadriceps muscle strength and ambulation ability better than FNBs, while providing equivalent pain relief5-9.

Recent randomized studies have also shown ACB to be superior to placebo in the setting of spinal and general intraoperative anesthesia in terms of ambulation, pain control, and opioid consumption10-12. In a recent retrospective cohort study, the addition of ACB to local infiltration analgesia (LIA) was associated with further improvement in early ambulation benchmarks and a higher rate of home discharge compared with only LIA9. While CACB and CSE are used as part of routine care at Rush University Medical Center and around the country, there have been no studies directly comparing CACB to CSE.

Study Design: Department funded, single center, prospective, randomized, parallel outcome based clinical trial. 300 subjects scheduled to undergo primary unilateral TKA will be randomized to receive CSE, CACB + General, or CACB + Spinal as per routine care. Subjects will be enrolled for no more than 6 weeks.

Power Analysis: Sample size calculations were based on the primary aim, of CACB plus Spinal anesthesia versus standard care (combined spinal epidural, CSE) improving ambulation distance at postoperative day 1 (POD1). Based on results from a pilot study we found that the CSE group had at POD1 a mean distance traveled of 159 feet with a standard deviation (SD) of 111 feet, while the CACB + Spinal anesthesia subjects walked over twice the distance on average with a similar SD.

To be conservative we expect both the CACB + Spinal anesthesia and CACB + General Anesthesia groups to walk at least 35% farther on average, or at least equal to CSE group.

Based on a one-way, 3-level AVOVA with the primary contrast of CABC + Spinal versus CSE at a 35% greater ambulation difference, for 90% power, with α of 5%, requires a sample size of 84 subjects per group. Increasing the sample size to 100 will provide for a 16% dropout rate. Total of 300 patients.

Treatment Groups:

  1. General Intraoperative Anesthesia with standard post-operative Continuous Adductor Canal Block (0.2% ropivacaine running at 6-8mL/hr) with standard post-operative analgesics.
  2. Spinal Intraoperative Anesthesia with standard post-operative Continuous Adductor Canal Block (0.2% ropivacaine running at 6-8mL/hr) with standard post-operative analgesics.
  3. Spinal Intraoperative Anesthesia with standard Epidural (0.1% bupivacaine with fentanyl 5 mcg/mL running at 6mL/hr with 1mL q15 bolus) with standard post-operative analgesics.

Demographics/Patient Specifics: Age, Sex, ASA score, Weight, Height, Operative Time, BMI, Walker, Cane, Unassisted Ambulation

Risks/Benefits:

Combined spinal epidural anesthesia, general anesthesia, and continuous adductor canal blocks are part of routine anesthesia care at Rush University Medical Center and around the country. Post-operative analgesia regiments are standard of care.

Risks of general anesthesia include sore throat, nausea/vomiting, potential tooth damage, vocal cord injury, mental confusion, awareness, stroke, death. Risks of regional anesthesia (spinal) include bleeding (spinal hematoma), infection (meningitis), nerve damage, headache, hypotension, difficulty urinating, and seizures. There is no difference between epidural catheter and adductor canal catheter in terms of risks, other than the adductor canal catheter carries no risk of headache. These risks are present regardless of the study since either general or spinal anesthesia is used in all total knee arthroplasty procedures.

The only risk involved in participating in the study is the potential for breach of confidentiality and/or privacy. Below is a description of the procedure for maintaining confidentiality. There is no direct benefit to the participants in this study.

Procedures for Maintaining Confidentiality A breach of confidentiality and/or privacy is a risk of this study. To prevent this, all collected data will be stored electronically in password-protected files to protect patient identity and information. All information will be collected and reviewed by the research team only. Data will be maintained on a password-protected computer that will be accessible only to the study team. No patient identifiers will be maintained in the database.

Conditions
Arthroplasty
Being tested
Continuous Adductor Canal Block, General, Epidural, Spinal
Keywords
Knee, Replacement

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Continuous Adductor Canal BlockProcedure or surgery

    Continuous Adductor Canal Block (0.2% ropivacaine running at 6-8mL/hr)

  • GeneralProcedure or surgery

    General Intraoperative Anesthesia

  • EpiduralProcedure or surgery

    Epidural (0.1% bupivacaine with fentanyl 5 mcg/mL running at 6mL/hr with 1mL q15 bolus)

  • SpinalProcedure or surgery

    Spinal Intraoperative Anesthesia

Study groups in NCT02415465
Study groupRoleWhat they receive
Combined Spinal EpiduralActive comparatorSpinal Intraoperative Anesthesia with standard Epidural (0.1% bupivacaine with fentanyl 5 mcg/mL running at 6mL/hr with 1mL q15 bolus) with standard post-operative analgesics.
Receives: Procedure: Epidural; Procedure: Spinal
General+Continuous Adductor Canal BlockActive comparatorGeneral Intraoperative Anesthesia with standard post-operative Continuous Adductor Canal Block (0.2% ropivacaine running at 6-8mL/hr) with standard post-operative analgesics.
Receives: Procedure: Continuous Adductor Canal Block; Procedure: General
Spinal+Continuous Adductor Canal BlockActive comparatorSpinal Intraoperative Anesthesia with standard post-operative Continuous Adductor Canal Block (0.2% ropivacaine running at 6-8mL/hr) with standard post-operative analgesics.
Receives: Procedure: Continuous Adductor Canal Block; Procedure: Spinal

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Ambulation Distance in feet

    Patient ambulation distance will be measured daily after surgery until discharge from hospital

    Measured: daily after surgery until discharge from hospital, expected average up to 5 days

Secondary outcomes (5)
  1. Straight Leg Raise

    Patient's ability to perform straight leg raise daily after surgery until discharge from hospital.

    Measured: daily after surgery until discharge from hospital, expected average up to 5 days

  2. Quadriceps strength

    Quadriceps strength evaluated using a standard non-invasive handheld dynamometer once pre-operatively and daily after surgery until discharged from hospital.

    Measured: daily after surgery until discharge from hospital, expected average up to 5 days

  3. Pain as measured by numeric pain score

    Post-operative numeric pain scores during rest and with activity during daily inpatient physical therapy sessions until discharge from hospital

    Measured: daily after surgery until discharge from hospital, expected average up to 5 days

  4. Post-operative inpatient opioid consumption (morphine equivalents)

    Post-operative inpatient opioid consumption (morphine equivalents) measured daily after surgery until discharge from hospital.

    Measured: daily after surgery until discharge from hospital, expected average up to 5 days

  5. Surgery Complications and Adverse Events during inpatient stay

    Surgery Complications and Adverse Events during inpatient stay

    1. Respiratory depression
    2. Sedation
    3. Nausea
    4. Emesis
    5. Motor Blockade
    6. Pruritus
    7. Urinary Retention
    8. Hypotension
    9. Numbness
    10. Falls
    11. DVT or PE
    12. Catheter Site Infection
    13. Block Success

    Measured: daily after surgery until discahrge from hospital, expected average up to 5 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Apr 2015 (estimated)
  2. Study startJan 2015
  3. Primary completionMar 2016
  4. Study completionMar 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
157 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02415465
Sponsor's protocol ID
14090501
Status last verified
Apr 2016
First submitted
6 Apr 2015
Last updated
15 Apr 2016
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Continuous Adductor Canal Block, General and Epidural in people with Arthroplasty, run by Rush University Medical Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Apr 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Ambulation Distance in feet (time frame: daily after surgery until discharge from hospital, expected average up to 5 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Apr 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in